Patents by Inventor Donald Wayne Mann

Donald Wayne Mann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF ASSESSING ANTI-PRURITIC ACTIVITY OF A CANINE ANTI-IL-31 ANTIBODY CANDIDATE
    Publication number: 20260159582
    Abstract: A method of assessing anti-pruritic activity of a canine anti-IL-31 antibody candidate is provided. The method includes determining whether there is a reduction in an observable feature associated with IL-31-mediated pruritus in a dog subsequent to administering the canine anti-IL-31 antibody candidate to the dog.
    Type: Application
    Filed: February 10, 2026
    Publication date: June 11, 2026
    Inventors: Donald Wayne Mann, James Taylor Curry, Robert B. McCall, William R. Humphrey, Andrea Joy Gonzales, Gary Francis Bammert, Steven Alan Dunham
  • METHOD OF ASSESSING ANTI-PRURITIC ACTIVITY OF A CANINE ANTI-IL-31 ANTIBODY CANDIDATE
    Publication number: 20260062474
    Abstract: A method of assessing anti-pruritic activity of a canine anti-IL-31 antibody candidate is provided. The method includes determining whether there is a reduction in an observable feature associated with IL-31-mediated pruritus in a dog subsequent to administering the canine anti-IL-31 antibody candidate to the dog.
    Type: Application
    Filed: May 8, 2025
    Publication date: March 5, 2026
    Inventors: Donald Wayne Mann, James Taylor Curry, Robert B. McCall, William R. Humphrey, Andrea Joy Gonzales, Gary Francis Bammert, Steven Alan Dunham
  • IL-31 dog pruritus model
    Patent number: 10526405
    Abstract: An IL-31 dog pruritus model is provided. This model comprises administering canine IL-31 to dogs to produce a pruritic response; quantitatively measuring pruritic responses in the dogs which were administered canine IL-31; administering a candidate dog IL-31 inhibitor; and assessing the effectiveness of the candidate dog IL-31 inhibitor in reducing prurtic behavior in the treated dogs by challenging the dogs with canine IL-31 following the administration of the candidate dog IL-31 inhibitor.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: January 7, 2020
    Assignee: Zoetis Services LLC
    Inventors: Donald Wayne Mann, James Taylor Curry, Robert B. McCall, William R. Humphrey, Andrea Joy Gonzales, Gary Francis Bammert, Steven Alan Dunham
  • IL-31 DOG PRURITUS MODEL
    Publication number: 20190359702
    Abstract: An IL-31 dog pruritus model is provided. This model comprises administering canine IL-31 to dogs to produce a pruritic response; quantitatively measuring pruritic responses in the dogs which were administered canine IL-31; administering a candidate dog IL-31 inhibitor; and assessing the effectiveness of the candidate dog IL-31 inhibitor in reducing prurtic behavior in the treated dogs by challenging the dogs with canine IL-31 following the administration of the candidate dog IL-31 inhibitor.
    Type: Application
    Filed: August 14, 2019
    Publication date: November 28, 2019
    Inventors: DONALD WAYNE MANN, JAMES TAYLOR CURRY, ROBERT B. MCCALL, WILLIAM R. HUMPHREY, ANDREA JOY GONZALES, GARY FRANCIS BAMMERT, STEVEN ALAN DUNHAM
  • Pyrrolo[2,3-D]pyrimidine compounds
    Patent number: 9271981
    Abstract: Described herein is pyrrolo{2,3-d}pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing this compounds, and methods for the preparation of these compounds.
    Type: Grant
    Filed: September 15, 2015
    Date of Patent: March 1, 2016
    Assignee: Zoetis Services LLC
    Inventors: Mark J. Mitton-Fry, Pamela J. Berlinski, Matthew J. Birchmeier, Jerry W. Bowman, Andrea Joy Gonzales, Steven Glenn Kamerling, Donald Wayne Mann
  • PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS
    Publication number: 20150374701
    Abstract: Described herein is pyrrolo {2,3-d}pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing this compounds, and methods for the preparation of these compounds.
    Type: Application
    Filed: September 15, 2015
    Publication date: December 31, 2015
    Inventors: Mark J. Mitton-Fry, Pamela J. Berlinski, Matthew J. Birchmeier, Jerry W. Bowman, Andrea Joy Gonzales, Steven Glenn Kamerling, Donald Wayne Mann
  • Pyrrolo[2,3-d]pyrimidine compounds
    Patent number: 9161939
    Abstract: Described herein is pyrrolo{2,3-d}pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing this compounds, and methods for the preparation of these compounds.
    Type: Grant
    Filed: February 11, 2015
    Date of Patent: October 20, 2015
    Assignee: Zoetis Services LLC
    Inventors: Mark J. Mitton-Fry, Pamela J. Berlinski, Matthew J. Birchmeier, Jerry W. Bowman, Andrea Joy Gonzales, Steven Glenn Kamerling, Donald Wayne Mann
  • PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS
    Publication number: 20150148357
    Abstract: Described herein is pyrrolo{2,3-d}pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing this compounds, and methods for the preparation of these compounds.
    Type: Application
    Filed: February 11, 2015
    Publication date: May 28, 2015
    Inventors: Mark J. Mitton-Fry, Pamela J. Berlinski, Matthew J. Birchmeier, Jerry W. Bowman, Andrea Joy Gonzales, Steven Glenn Kamerling, Donald Wayne Mann
  • Pyrrolo[2,3-D]pyrimidine compounds
    Patent number: 8987283
    Abstract: Described herein is pyrrolo{2,3-d}pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing this compounds, and methods for the preparation of these compounds.
    Type: Grant
    Filed: January 30, 2012
    Date of Patent: March 24, 2015
    Assignee: Zoetis LLC
    Inventors: Mark J. Mitton-Fry, Pamela J. Berlinski, Matthew J. Birchmeier, Jerry W. Bowman, Andrea Joy Gonzales, Steven Glenn Kamerling, Donald Wayne Mann
  • PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS
    Publication number: 20120122901
    Abstract: Described herein is pyrrolo{2,3-d}pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing this compounds, and methods for the preparation of these compounds.
    Type: Application
    Filed: January 30, 2012
    Publication date: May 17, 2012
    Applicant: PFIZER INC.
    Inventors: Mark J. Mitton-Fry, Pamela J. Berlinski, Matthew J. Birchmeier, Jerry W. Bowman, Andrea Joy Gonzales, Steven Glenn Kamerling, Donald Wayne Mann
  • Pyrrolo[2,3-]pyrimidine compounds
    Patent number: 8133899
    Abstract: Described herein is pyrrolo{2,3-d}pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing this compounds, and methods for the preparation of these compounds.
    Type: Grant
    Filed: August 17, 2009
    Date of Patent: March 13, 2012
    Assignee: Pfizer Inc.
    Inventors: Mark J. Mitton-Fry, Pamela J. Berlinski, Matthew J. Birchmeier, Jerry W. Bowman, Andrea Joy Gonzales, Steven Glenn Kamerling, Donald Wayne Mann
  • PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS
    Publication number: 20100075996
    Abstract: Described herein is pyrrolo{2,3-d}pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing this compounds, and methods for the preparation of these compounds.
    Type: Application
    Filed: August 17, 2009
    Publication date: March 25, 2010
    Applicant: PFIZER INC.
    Inventors: Mark J. Mitton-Fry, Pamela J. Berlinski, Matthew J. Birchmeier, Jerry W. Bowman, Andrea Joy Gonzales, Steven Glenn Kamerling, Donald Wayne Mann